Evaluation of RETmRNA expression in malignant tumors of the salivary glands
- Authors: Kutukova S.I1,2, Imyanitov E.N3, Ivaskova Y.V1,2, Belyak N.P1,4, Razumova A.Y.2
-
Affiliations:
- City Clinical Oncology Dispensary
- Pavlov First St. Petersburg State Medical University
- N.N. Petrov National Medical Research Center of Oncology
- St. Petersburg State University
- Issue: Vol 26, No 12 (2019)
- Pages: 56-59
- Section: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/312341
- DOI: https://doi.org/10.18565/pharmateca.2019.12.56-58
- ID: 312341
Cite item
Abstract
Full Text
About the authors
S. I Kutukova
City Clinical Oncology Dispensary; Pavlov First St. Petersburg State Medical University
Email: dr.s.kutukova@gmail.com
PhD, Oncologist, Chemotherapy Department (№ 11), City Clinical Oncology Dispensary; Associate Professor, Department of Suigical Dentistry and Maxillofacial Surgery 56, Veteranov Avenue, St. Petersburg, 198255, Russian Federation
E. N Imyanitov
N.N. Petrov National Medical Research Center of OncologySt. Petersburg, Russia
Yu. V Ivaskova
City Clinical Oncology Dispensary; Pavlov First St. Petersburg State Medical UniversitySt. Petersburg, Russia
N. P Belyak
City Clinical Oncology Dispensary; St. Petersburg State UniversitySt. Petersburg, Russia
A. Ya Razumova
Pavlov First St. Petersburg State Medical UniversitySt. Petersburg, Russia
References
- Van Dijk B.A., Gatta G., Capocaccia R., et aI., RARECARE Working group. RARECARE Working group. Rare cancers of the head and neck area in Europe. Eur J Cancer. 2012;48:783e96. doi: 10.1016/j.ejca.2011.08.021.
- Barnes L., Evenson J.W., Reichart P, Sidransky D. Salivary glands. In: World Health Organization classification of tumours: pathology & genetics of head and neck tumours. Lyon, France: IARC. Press, 2005. P 209e81.
- Storey M.R., Garden A.S., Morrison W.H., et al. Postoperative radiotherapy for malignant tumors of the submandibular gland. Int J Radiat Oncol Biol Phys. 2001;51:952e8.
- Белоус Т.А. Эпителиальные опухоли слюнных желез. Дис. канд. мед. наук. М., 1978. [Belous T.A. Epithelial tumors salivary glands. Diss. Cand. of Med. Sciences. M., 1978. (In Russ.)].
- Holmes T, Das R., Low D., et al. IMRT Documentation Working Group. American Society of Radiation Oncology recommendation for documenting intensity-modulated radiation therapy treatments. Int J Radiat Oncol Biol Phys. 2009;74(5):1311-18.
- Lee N.Y., O'Meara W., Chan K., et al. Concurrent chemotherapy and intensity- modulated radiotherapy for locoregiolnaly advanced laryngeal and hypopharyngeal. Int J Radiat. Oncol Biol Phys. 2007;69(2): 459-68. Doi: 10.1016/j. ijrobp.2007.03.013.
- NCCN Clinical Practice Guidelines in Oncology. Salivary Gland Tumors. Head and Neck Cancer, 2019. Version 1. Part 1.
- Laurie S.A., Ho A.L., Fury M.G., et al. Systemic therapy in the management of metastatic or locally recurrent adenoid cystic carcinoma of the salivary glands: a systematic review. Lancet. Oncol. 2011;12:815e24. doi: 10.1016/S1470-2045(10)70245-X
- Eneroth C.M. Salivary gland tumors in the parotid gland, submandibular gland, and the palate region. Cancer. 1971;27:1415-18.
- Вайрадян В.Т., Мудунов А.М., Ермилова В.Д. и др. Анализ результатов лечения больных со злокачественными опухолями слюнных желез. Опухоли головы и шеи, 2016;6(3):42-52
- Bunone G., Uggeri M., Mondellini P, et al. RET receptor expression in thyroid follicular epithelial cell-derived tumors. Cancer Res. 2000; 60:2845-49.
- Locati L.D., Perrone F, Cortelazzi B., et al. A phase II study of sorafenib in recurrent and/or metastatic salivary gland carcinomas: Translational analyses and clinical impact. Eur J Cancer. 2016;69:158-65. Doi: https://doi.org/10.1016/j.ejca. 2016.09.022.